The primary cause of gas exchange impairment in COVID-19 is thought to be different from regular acute respiratory distress syndrome (ARDS). There has been controversy regarding inhaled nitric oxide.

The primary cause of gas exchange impairment in COVID-19 is thought to be different from regular acute respiratory distress syndrome (ARDS). There has been controversy regarding inhaled nitric oxide. Some studies have shown some mild benefit, with a response rate of 65% improvement in patients who had nitric oxide administration at 10 parts per million. But other studies have shown no improvement in ventilation or oxygenation. In mechanically ventilated patients with COVID-19 ARDS, there is a recommendation against the use of inhaled nitric oxide except as a last-ditch effort. How are you proceeding in your individual practices?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on January 13, 2021.

Moderator: Michelle M. Ramírez, MD, FAAP 

Faculty:
Pedro J. Rivera, MD (TH) 
Gina Hurst, MD 

This educational activity was funded in part by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 1 NU50CK000566-01-00). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). Its contents do not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.

Estimated Time: 03:34